Published online October 1, 2004
PEDIATRICS Vol. 114 No. 4 October 2004, pp. 1065-1069 (doi:10.1542/peds.2004-0440)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meissner, H. C.
Right arrow Articles by Orenstein, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meissner, H. C.
Right arrow Articles by Orenstein, W. A.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Measles
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SPECIAL ARTICLE

Measles Vaccines and the Potential for Worldwide Eradication of Measles

H. Cody Meissner, MD*, Peter M. Strebel, MD{ddagger} and Walter A. Orenstein, MD§

* Division of Pediatric Infectious Disease, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts
{ddagger} National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia
§ Emory Vaccine Center, Emory University, Atlanta, Georgia

The annual number of reported measles cases in the United States has declined from between 3 million and 4 million in the prevaccine era to <100 cases in association with the highest recorded immunization rates in history. Because of continued importation of measles into the United States, young children who are not vaccinated appropriately may experience more than a 60-fold increase in risk of disease. Unsubstantiated claims suggesting an association between measles vaccine and neurologic disorders have led to reduced vaccine use and a resurgence of measles in countries where immunization rates have declined below the level needed to maintain herd immunity. To address the possibility of worldwide control of measles, efforts to ensure high immunization rates among people in both developed and developing countries must be sustained.

Key Words: bioterrorism • measles-mumps-rubella vaccine • vaccines • measles • autism

Abbreviations: MMR, measles-mumps-rubella • ASD, autism spectrum disorders

Accepted Jun 9, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
P. Asaria and E. MacMahon
Measles in the United Kingdom: can we eradicate it by 2010?
BMJ, October 28, 2006; 333(7574): 890 - 895.
[Full Text] [PDF]

Home page
 PediatricsHome page
A. M. Fine, D. A. Goldmann, P. W. Forbes, S. K. Harris, and K. D. Mandl
Incorporating Vaccine-Preventable Disease Surveillance Into the National Health Information Network: Leveraging Children's Hospitals
Pediatrics, October 1, 2006; 118(4): 1431 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Y. D'Souza, E. Fombonne, and B. J. Ward
No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells From Children With Autism Spectrum Disorder
Pediatrics, October 1, 2006; 118(4): 1664 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
I. D. Iankov, M. Pandey, M. Harvey, G. E. Griesmann, M. J. Federspiel, and S. J. Russell
Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
J. Virol., September 1, 2006; 80(17): 8530 - 8540.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
E. M. Bublil, S. Yeger-Azuz, and J. M. Gershoni
Computational prediction of the cross-reactive neutralizing epitope corresponding to the monoclonal antibody b12 specific for HIV-1 gp120
FASEB J, September 1, 2006; 20(11): 1762 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. C. Meissner, S. E. Reef, and S. Cochi
Elimination of Rubella From the United States: A Milestone on the Road to Global Elimination
Pediatrics, March 1, 2006; 117(3): 933 - 935.
[Full Text] [PDF]

Home page
 PediatricsHome page
K. M. Posfay-Barbe, U. Heininger, C. Aebi, D. Desgrandchamps, B. Vaudaux, and C.-A. Siegrist
How Do Physicians Immunize Their Own Children? Differences Among Pediatricians and Nonpediatricians
Pediatrics, November 1, 2005; 116(5): e623 - e633.
[Abstract] [Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
A. M. Stern and H. Markel
The History Of Vaccines And Immunization: Familiar Patterns, New Challenges
Health Aff., May 1, 2005; 24(3): 611 - 621.
[Abstract] [Full Text] [PDF]